These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 2367393)

  • 1. [Significance of ofloxacin for the treatment of infection-exacerbated chronic obstructive lung disease].
    Stapel A; Freymann H; Ruge W
    Pneumologie; 1990 Feb; 44 Suppl 1():289-90. PubMed ID: 2367393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
    Liam CK; Aziah AM; Lim KH; Wong CM
    Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin.
    Stocks JM; Wallace RJ; Griffith DE; Garcia JG; Kohler RB
    Am J Med; 1989 Dec; 87(6C):52S-56S. PubMed ID: 2690620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of Visiren administration in patients with respiratory infections].
    Plavsić Z; Filipović M; Popovac D
    Srp Arh Celok Lek; 1990; 118(11-12):455-7. PubMed ID: 2133600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ofloxacin in the treatment of infections of the respiratory tract in older patients].
    Krcméry V; Cernák P; Cepcek P
    Cas Lek Cesk; 1990 Mar; 129(10):309-11. PubMed ID: 2340551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin].
    Chuard C; Regamey C
    Schweiz Med Wochenschr; 1989 Dec; 119(52):1913-6. PubMed ID: 2692153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease.
    Watanabe A
    Infection; 1991; 19 Suppl 7():S384-7. PubMed ID: 1804788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of ofloxacin (Tarivid) therapy in respiratory and urinary tract infections].
    Hasçelik G
    Mikrobiyol Bul; 1987 Jul; 21(3):165-71. PubMed ID: 3332699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ofloxacin in the treatment of lower respiratory tract infections in patients with chronic pulmonary diseases].
    Marcos Sánchez F; Aparicio Martínez JC; Celdrán Gil J; Durán Pérez-Navarro A
    An Med Interna; 1992 Aug; 9(8):411-2. PubMed ID: 1391568
    [No Abstract]   [Full Text] [Related]  

  • 11. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory tract infections: at-risk patients, who are they? Implications for their management with levofloxacin.
    Cantón R; Lode H; Graninger W; Milkovich G
    Int J Antimicrob Agents; 2006 Sep; 28 Suppl 2():S115-27. PubMed ID: 16904873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opportunistic lung infections in patients with chronic obstructive lung disease; a side effect of inhalation corticosteroids?].
    Smeenk FW; Klinkhamer PJ; Breed W; Jansz AR; Jansveld CA
    Ned Tijdschr Geneeskd; 1996 Jan; 140(2):94-8. PubMed ID: 8569928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of ofloxacin versus cefazolin in lower respiratory tract infections.
    Bariffi F; Giacomelli P; Sanduzzi A; Perna F; De Masi AL
    Int J Clin Pharmacol Res; 1987; 7(3):199-201. PubMed ID: 3474212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of ofloxacin in complicated urinary tract infection].
    Akazawa N; Tsugawa M; Hayata S; Sasaki H; Asahi T; Okita K
    Hinyokika Kiyo; 1988 Jul; 34(7):1279-82. PubMed ID: 3177148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nocardia respiratory infection in patients with chronic obstructive lung disease].
    Lacassagne L; Didier A; Murrisespin M; Rouquet RM; Clave D; Lemozy J; Giron J; Leophonte P
    Rev Mal Respir; 1996; 13(4):433-6. PubMed ID: 8927798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic obstructive respiratory tract diseases: standards and trends of antibiotic therapy].
    Feist H; Armbruster C; Kapfhammer G; Vetter N; Drlicek M; Hackl H
    Prax Klin Pneumol; 1988 Jul; 42(7):529-32. PubMed ID: 3186652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical studies of ofloxacin 300 mg once a day administration in chronic respiratory tract infections].
    Fukuhara H; Kusano N; Irabu Y; Shigeno Y; Saito A; Nakamura H; Horimoto S; Shimozi T; Miyagi M; Inadame J
    Jpn J Antibiot; 1993 Jan; 46(1):60-6. PubMed ID: 8455332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial therapy in ro cases of obstructive chronic bronchopneumopathy].
    Noya M; Del Río A
    Rev Clin Esp; 1971 Apr; 121(1):47-50. PubMed ID: 5563102
    [No Abstract]   [Full Text] [Related]  

  • 20. An open, non comparative study of ofloxacin i.v. on the treatment of acute symptomatic urinary tract infection.
    Asvanich K; Fugpholngam V; Srimuang S; Tanphaichitra D
    J Med Assoc Thai; 2000 Jul; 83(7):771-5. PubMed ID: 10932512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.